Application of vitamin D and derivatives in hematological malignancies

Minji Kim, Leonardo Mirandola, Apurva Pandey, Diane D. Nguyen, Marjorie R. Jenkins, Meryem Turcel, Everardo Cobos, Maurizio Chiriva-Internati

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The role of vitamin D in the inhibition of malignant cell proliferation in hematological malignancies is indicative of its future use in cancer therapy. An understanding of the biochemical mechanism by which vitamin D and its derivatives exert their effects will prove to be useful in the development of clinically applicable therapies involving vitamin D. While the use of vitamin D in clinical trials against acute myeloid leukemia and myelodysplastic syndrome has been met with few successes thus far,. in vitro and. in vivo studies as well as epidemiological correlations between vitamin D deficiency and cancer have implicated the great potential of the use of vitamin D derivatives in effective therapies against neoplastic diseases. For these reasons, a focus on current understanding of role of vitamin D and derivatives in hematologic malignancies is relevant and the goal for this review.

Original languageEnglish (US)
Pages (from-to)8-22
Number of pages15
JournalCancer Letters
Volume319
Issue number1
DOIs
StatePublished - Jun 1 2012

Fingerprint

Hematologic Neoplasms
Vitamin D
Vitamin D Deficiency
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Neoplasms
Therapeutics
Cell Proliferation
Clinical Trials

Keywords

  • Clinical trials
  • Hematological malignancies
  • Intracellular kinases
  • Multiple myeloma
  • Vitamin D

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kim, M., Mirandola, L., Pandey, A., Nguyen, D. D., Jenkins, M. R., Turcel, M., ... Chiriva-Internati, M. (2012). Application of vitamin D and derivatives in hematological malignancies. Cancer Letters, 319(1), 8-22. https://doi.org/10.1016/j.canlet.2011.10.026

Application of vitamin D and derivatives in hematological malignancies. / Kim, Minji; Mirandola, Leonardo; Pandey, Apurva; Nguyen, Diane D.; Jenkins, Marjorie R.; Turcel, Meryem; Cobos, Everardo; Chiriva-Internati, Maurizio.

In: Cancer Letters, Vol. 319, No. 1, 01.06.2012, p. 8-22.

Research output: Contribution to journalArticle

Kim, M, Mirandola, L, Pandey, A, Nguyen, DD, Jenkins, MR, Turcel, M, Cobos, E & Chiriva-Internati, M 2012, 'Application of vitamin D and derivatives in hematological malignancies', Cancer Letters, vol. 319, no. 1, pp. 8-22. https://doi.org/10.1016/j.canlet.2011.10.026
Kim M, Mirandola L, Pandey A, Nguyen DD, Jenkins MR, Turcel M et al. Application of vitamin D and derivatives in hematological malignancies. Cancer Letters. 2012 Jun 1;319(1):8-22. https://doi.org/10.1016/j.canlet.2011.10.026
Kim, Minji ; Mirandola, Leonardo ; Pandey, Apurva ; Nguyen, Diane D. ; Jenkins, Marjorie R. ; Turcel, Meryem ; Cobos, Everardo ; Chiriva-Internati, Maurizio. / Application of vitamin D and derivatives in hematological malignancies. In: Cancer Letters. 2012 ; Vol. 319, No. 1. pp. 8-22.
@article{5bd99e4df8ff4a5c97bb9772a522a146,
title = "Application of vitamin D and derivatives in hematological malignancies",
abstract = "The role of vitamin D in the inhibition of malignant cell proliferation in hematological malignancies is indicative of its future use in cancer therapy. An understanding of the biochemical mechanism by which vitamin D and its derivatives exert their effects will prove to be useful in the development of clinically applicable therapies involving vitamin D. While the use of vitamin D in clinical trials against acute myeloid leukemia and myelodysplastic syndrome has been met with few successes thus far,. in vitro and. in vivo studies as well as epidemiological correlations between vitamin D deficiency and cancer have implicated the great potential of the use of vitamin D derivatives in effective therapies against neoplastic diseases. For these reasons, a focus on current understanding of role of vitamin D and derivatives in hematologic malignancies is relevant and the goal for this review.",
keywords = "Clinical trials, Hematological malignancies, Intracellular kinases, Multiple myeloma, Vitamin D",
author = "Minji Kim and Leonardo Mirandola and Apurva Pandey and Nguyen, {Diane D.} and Jenkins, {Marjorie R.} and Meryem Turcel and Everardo Cobos and Maurizio Chiriva-Internati",
year = "2012",
month = "6",
day = "1",
doi = "10.1016/j.canlet.2011.10.026",
language = "English (US)",
volume = "319",
pages = "8--22",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Application of vitamin D and derivatives in hematological malignancies

AU - Kim, Minji

AU - Mirandola, Leonardo

AU - Pandey, Apurva

AU - Nguyen, Diane D.

AU - Jenkins, Marjorie R.

AU - Turcel, Meryem

AU - Cobos, Everardo

AU - Chiriva-Internati, Maurizio

PY - 2012/6/1

Y1 - 2012/6/1

N2 - The role of vitamin D in the inhibition of malignant cell proliferation in hematological malignancies is indicative of its future use in cancer therapy. An understanding of the biochemical mechanism by which vitamin D and its derivatives exert their effects will prove to be useful in the development of clinically applicable therapies involving vitamin D. While the use of vitamin D in clinical trials against acute myeloid leukemia and myelodysplastic syndrome has been met with few successes thus far,. in vitro and. in vivo studies as well as epidemiological correlations between vitamin D deficiency and cancer have implicated the great potential of the use of vitamin D derivatives in effective therapies against neoplastic diseases. For these reasons, a focus on current understanding of role of vitamin D and derivatives in hematologic malignancies is relevant and the goal for this review.

AB - The role of vitamin D in the inhibition of malignant cell proliferation in hematological malignancies is indicative of its future use in cancer therapy. An understanding of the biochemical mechanism by which vitamin D and its derivatives exert their effects will prove to be useful in the development of clinically applicable therapies involving vitamin D. While the use of vitamin D in clinical trials against acute myeloid leukemia and myelodysplastic syndrome has been met with few successes thus far,. in vitro and. in vivo studies as well as epidemiological correlations between vitamin D deficiency and cancer have implicated the great potential of the use of vitamin D derivatives in effective therapies against neoplastic diseases. For these reasons, a focus on current understanding of role of vitamin D and derivatives in hematologic malignancies is relevant and the goal for this review.

KW - Clinical trials

KW - Hematological malignancies

KW - Intracellular kinases

KW - Multiple myeloma

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84862809395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862809395&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2011.10.026

DO - 10.1016/j.canlet.2011.10.026

M3 - Article

VL - 319

SP - 8

EP - 22

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -